What is the address of MEDISEC CONSULTING?

The registered office of MEDISEC CONSULTING is located at Sint-Annastraat 218, 9220 Hamme (Vl.).

Is MEDISEC CONSULTING still active?

Yes. According to the CBE (29 October 2026) MEDISEC CONSULTING is active, legal situation “Normale toestand”, started on 8 July 2005.

Is MEDISEC CONSULTING registered on Peppol?

Yes, MEDISEC CONSULTING is registered on the Peppol network with ID 0208:0874955242.

What is the enterprise number of MEDISEC CONSULTING?

The enterprise number of MEDISEC CONSULTING is BE0874955242.

When was MEDISEC CONSULTING founded?

MEDISEC CONSULTING was founded on 8 July 2005.

Who are the directors of MEDISEC CONSULTING?

According to the 2025 annual accounts, the directors of MEDISEC CONSULTING are: Danielle Wijk, Rottiers Hans.

Is MEDISEC CONSULTING a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 July 2005; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDISEC CONSULTING make in 2025?

MEDISEC CONSULTING posted a profit after taxes of € 176,745 in financial year 2025.

What is the revenue of MEDISEC CONSULTING?

As a small company, MEDISEC CONSULTING is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -90,352.

How many employees does MEDISEC CONSULTING have?

According to the 2025 annual accounts, MEDISEC CONSULTING has 0 full-time equivalents (FTE).

MEDISEC CONSULTING (Private Limited) - Hamme (Vl.)

Q: What does MEDISEC CONSULTING do?

MEDISEC CONSULTING is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 8 July 2005, 1 establishment.

Dossier MEDISEC CONSULTING, printed on 29 October 2026 from databakkes.be/en/0874955242/medisec-consulting. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Late annual account NBB

Fiscal year 2025 was filed 326 days after the legal deadline.

Financials

Financial year 2025

MEDISEC CONSULTING from Hamme (Vl.), company number BE0874955242, closed financial year 2025 with a result of € 176,745 after tax. For that financial year MEDISEC CONSULTING recorded a gross margin of € -90,352 and equity of € 1 million. Compared with financial year 2024, the result moved from € 68,454 to € 176,745. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 22, 2026.

What it is worth Growing

€ 1 million

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 176,745

▲ 158% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 238,191

▲ € 226,878 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 136,426 paid out

77 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 27,153

▲ € 23,764 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 316,156

▼ 12% vs 2024

€ 46,773 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 6,915

▼ 63% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 94,422

▲ 73% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 164,509 Gross margin 2022: € 164,509 First fiscal year in the series	€ 203,798 Gross margin 2023: € 203,798 ▲ 24% vs 2022 (€ 164,509) Favourable step	€ 183,093 Gross margin 2024: € 183,093 ▼ 10% vs 2023 (€ 203,798) Unfavourable step	€ -90,352 Gross margin 2025: € -90,352 ▼ € 273,445 vs 2024 (€ 183,093) Unfavourable step	▼ € 273,445
Profit after taxes	€ 70,214 Profit after taxes 2022: € 70,214 First fiscal year in the series	€ 90,962 Profit after taxes 2023: € 90,962 ▲ 30% vs 2022 (€ 70,214) Favourable step	€ 68,454 Profit after taxes 2024: € 68,454 ▼ 25% vs 2023 (€ 90,962) Unfavourable step	€ 176,745 Profit after taxes 2025: € 176,745 ▲ 158% vs 2024 (€ 68,454) Favourable step	▲ 158%
Equity	€ 1,008,932 Equity 2022: € 1,008,932 First fiscal year in the series	€ 994,795 Equity 2023: € 994,795 ▼ 1% vs 2022 (€ 1,008,932) Unfavourable step	€ 973,771 Equity 2024: € 973,771 ▼ 2% vs 2023 (€ 994,795) Unfavourable step	€ 1,014,090 Equity 2025: € 1,014,090 ▲ 4% vs 2024 (€ 973,771) Favourable step	▲ 4%
Total debts	€ 77,662 Total debts 2022: € 77,662 First fiscal year in the series	€ 409,364 Total debts 2023: € 409,364 ▲ € 331,702 vs 2022 (€ 77,662) Unfavourable step	€ 438,010 Total debts 2024: € 438,010 ▲ 7% vs 2023 (€ 409,364) Unfavourable step	€ 450,045 Total debts 2025: € 450,045 ▲ 3% vs 2024 (€ 438,010) Unfavourable step	▲ 3%
Cash	€ 62,618 Cash 2022: € 62,618 First fiscal year in the series	€ 192,305 Cash 2023: € 192,305 ▲ 207% vs 2022 (€ 62,618) Favourable step	€ 11,312 Cash 2024: € 11,312 ▼ 94% vs 2023 (€ 192,305) Unfavourable step	€ 238,191 Cash 2025: € 238,191 ▲ € 226,878 vs 2024 (€ 11,312) Favourable step	▲ € 226,878
Land & buildings	€ 511,602 Land & buildings 2022: € 511,602 First fiscal year in the series	€ 471,426 Land & buildings 2023: € 471,426 ▼ 8% vs 2022 (€ 511,602) Unchanged	€ 431,250 Land & buildings 2024: € 431,250 ▼ 9% vs 2023 (€ 471,426) Unchanged	€ 391,355 Land & buildings 2025: € 391,355 ▼ 9% vs 2024 (€ 431,250) Unchanged	▼ 9%
Retained profit	€ 793,932 Retained profit 2022: € 793,932 First fiscal year in the series	€ 779,795 Retained profit 2023: € 779,795 ▼ 2% vs 2022 (€ 793,932) Unfavourable step	€ 758,771 Retained profit 2024: € 758,771 ▼ 3% vs 2023 (€ 779,795) Unfavourable step	€ 799,090 Retained profit 2025: € 799,090 ▲ 5% vs 2024 (€ 758,771) Favourable step	▲ 5%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 105,099 Dividend 2023: € 105,099 Unchanged (€ 0) Unchanged	€ 89,478 Dividend 2024: € 89,478 ▼ 15% vs 2023 (€ 105,099) Unchanged	€ 136,426 Dividend 2025: € 136,426 ▲ 52% vs 2024 (€ 89,478) Unchanged	▲ 52%
Bank debt	€ 42,869 Bank debt 2022: € 42,869 First fiscal year in the series	€ 319,610 Bank debt 2023: € 319,610 ▲ € 276,740 vs 2022 (€ 42,869) Unfavourable step	€ 360,963 Bank debt 2024: € 360,963 ▲ 13% vs 2023 (€ 319,610) Unfavourable step	€ 316,156 Bank debt 2025: € 316,156 ▼ 12% vs 2024 (€ 360,963) Favourable step	▼ 12%
Balance sheet total	€ 1,086,594 Balance sheet total 2022: € 1,086,594 First fiscal year in the series	€ 1,404,159 Balance sheet total 2023: € 1,404,159 ▲ 29% vs 2022 (€ 1,086,594) Unchanged	€ 1,411,781 Balance sheet total 2024: € 1,411,781 ▲ 1% vs 2023 (€ 1,404,159) Unchanged	€ 1,464,135 Balance sheet total 2025: € 1,464,135 ▲ 4% vs 2024 (€ 1,411,781) Unchanged	▲ 4%

Key figures of MEDISEC CONSULTING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to MEDISEC CONSULTING?

What happened at MEDISEC CONSULTING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 22, 2026 New annual accounts for financial year 2025: profit of € 176,745 (▲ 158% vs 2024). filed late Source: NBB ↗
Aug 10, 2005 New establishment in Aalst. KBO
Jul 8, 2005 Start of the company according to the CBE. KBO

In short

From € 70,214 profit in 2022 to € 176,745 profit in 2025.

Paid € 124,514 in corporate taxes since 2022.

Best year ever: 2025, with € 176,745 profit.

Paid out € 331,002 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Danielle Wijk

Rottiers Hans

MEDISEC CONSULTING

Limaro Nv 100%

Behind MEDISEC CONSULTING are Danielle Wijk and Rottiers Hans. It owns 100% of Limaro Nv itself.

Directors

According to the 2025 annual accounts

Danielle Wijk

Director

Rottiers Hans

Director

Also active at: COBRA TECHNOLOGY

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Annastraat 218

9220 Hamme (Vl.)

2.148.404.696

Essenlaan 2

9308 Aalst

Active since 10 August 2005

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

THALIMVEST

€ 41,310 gross margin · 2024

LIMARO same network

€ -2,031 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0874.955.242

VAT number

BE 0874.955.242

Registered office

Sint-Annastraat 218, 9220 Hamme (Vl.)

Names & denominations

MEDISEC CONSULTING

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

8 July 2005

Peppol

Active · Active since 21 Nov 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISEC CONSULTING

Warning lights

Financials

What happened to MEDISEC CONSULTING?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions